Showing results (81-90 of 113) with videos related to

Sort By:
Pageof 12
Psychiatry Research|June 17, 2014
Pharmacogenetics of adverse events in schizophrenia treatment: comparison study of ziprasidone, olanzapine and perazinePiotr Tybura, Beata Trześniowska-Drukała, Przemyslaw Bienkowski, et al.
Molecular Biology Reports|September 26, 2013
Genetic variants in transforming growth factor-β gene (TGFB1) affect susceptibility to schizophreniaDorota Frydecka, Blazej Misiak, Jan Aleksander Beszlej, et al.
Social Psychiatry and Psychiatric Epidemiology|September 12, 2013
Money matters: does the reimbursement policy for second generation antipsychotics influence the number of recorded schizophrenia patients and the burden of stigmatization?Andrzej Kiejna, Blazej Misiak, Marta Zagdanska, et al.
Journal of Clinical Medicine|December 1, 2020
Adverse Childhood Experiences and Methylation of the <i>FKBP5</i> Gene in Patients with Psychotic DisordersBłażej Misiak, Paweł Karpiński, Elżbieta Szmida, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|July 18, 2021
Thyroid hormones in persons with schizophrenia: A systematic review and meta-analysisBłażej Misiak, Bartłomiej Stańczykiewicz, Michał Wiśniewski, et al.
Pharmacological Reports : PR|July 21, 2012
Some dopaminergic genes polymorphisms are not associated with response to antipsychotic drugs in schizophrenic patientsPiotr Tybura, Agnieszka Samochowiec, Aleksander Beszlej, et al.
Psychoneuroendocrinology|March 19, 2021
Immune-inflammatory markers and psychosis risk: A systematic review and meta-analysisBłażej Misiak, Francesco Bartoli, Giuseppe Carrà, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|December 1, 2018
A systematic review on the relationship between mental health, radicalization and mass violenceBłażej Misiak, Jerzy Samochowiec, Kamaldeep Bhui, et al.
Pageof 12